News & Events

ASU proves its patent prowess with global ranking

June 17, 2015

Michael Kozicki is no stranger to patents. The Arizona State University professor – who has 50 here in the U.S. and about 30 foreign equivalents – has had so many significant patents that he was inducted into the National Academy of Inventors in March. That was no easy feat, he said. “You have to be an evil genius, basically,” said Kozicki, who is with the School of Electrical, Computer and Energy Engineering in the Ira A. Fulton Schools of Engineering. “You have to have...

ASU spinout HealthTell among top five "start-ups to watch"

January 28, 2015

ASU Biodesign Institute spinout, HealthTell, landed on San Francisco Business Times reporter Ron Leuty's top five start-ups to potentially "win big" for 2015.  "Picking five Bay Area companies to watch this year is just as difficult, if only because I'm limiting myself to five," wrote Leuty. "The companies, are there for a batch of reasons — not just because they might turn out a blockbuster drug. In fact, only one is likely to bring a product to market this year." His writes...

Alliance Beverage donates $25,000 to ASU Biodesign Institute

December 23, 2014

Alliance Beverage Charity Golf Classic supports research into melanoma detection Most Arizona golfers know that they should guard against the risks of skin cancer. But few realize that Arizona has some of the highest rates of skin cancer in the world. This year, hundreds of golfers at the Alliance Beverage Charity Golf Classic are helping raise awareness and advance research. Their donation of $25,000 will help accelerate the development of a technology aimed at detecting melanoma – the...

HealthTell Announces Receipt of an NIH/NCI Grant to Detect the Presence of Brain Cancer

December 2, 2014

SAN RAMON, Calif.,  -- HealthTell(TM), an early stage Life Sciences company, today announced it has been awarded a $225,000 SBIR grant (1R43CA183360-01) from the National Institutes of Health (NIH) to evaluate the performance of the company's proprietary Immunosignature(TM) Technology in accurately diagnosing brain cancer. This will include the specific diagnosis of glioblastoma multiforme (GBM), the most common and aggressive malignant brain tumor. The project, conducted in...

New technology shows promise in taking the guesswork out of vaccine development

October 28, 2013

Scientists from the Center for Innovations in Medicine in the Biodesign Institute at Arizona State University have developed a comprehensive, microchip-based technology, called immunosignature diagnosis, which can rapidly and comprehensively measure an individual’s vaccine response, promising to take much of the initial guesswork out of predicting effective vaccines.  Professor Stephen Albert Johnston and Joseph Barten Legutki, used a mouse model of influenza infection to determine...

Advanced genetic screening method may speed vaccine development

May 9, 2012

Infectious diseases—both old and new—continue to exact a devastating toll, causing some 13 million fatalities per year around the world. Vaccines remain the best line of defense against deadly pathogens and now Kathryn Sykes and Stephen Johnston, researchers at Arizona State University’s Biodesign Institute, along with co-author Michael McGuire from the University of Texas Southwestern Medical Center are using clever functional screening methods to attempt to speed new vaccines into...

Dear John, You Have Psoriasis

September 26, 2011

by Stephen Albert Johnston, Ph.D. As an inventor, I place a lot of weight on understanding the words I use to describe the problem I am addressing. For example, in medicine, the word patient is from the Latin patiens, meaning to suffer or long endure. It’s a word with both social and moral implications, and it reflects our fundamental approach to medicine: we wait until you have a complaint, and then we try to treat it. Still, everyone agrees that it’d be better if medicine prevented...

Biodesign Institute at ASU receives 2-year, $5.3 million DARPA award for safeguarding soldiers from infectious diseases

September 10, 2010

Scientists at the Biodesign Institute at Arizona State University have received a 2-year, $5.3 million grant from the Defense Advanced Research Projects Agency (DARPA) to protect warfighters in the event of exposure to infectious diseases during deployment. Dr. Stephen Albert Johnston and his colleagues at the Biodesign Institute have taken on a daunting test of skill: to develop a potential therapeutic that can protect soldiers against an unknown pathogen—and do it in a week. Any...

Harnessing the immune system’s diagnostic power

June 7, 2010

An inexpensive system for earlier disease diagnosis could save innumerable lives. It would also have a profound impact on the nation’s healthcare industry, currently buckling under the strain of spiraling costs. Now Dr. Bart Legutki, a researcher at the Biodesign Institute at Arizona State University has pioneered a method for profiling the immune system, using clues provided by antibody activity to track an individual’s state of health.  The work was done in collaboration with Dr....